ChemoMetec Statistics

Total Valuation

ChemoMetec has a market cap or net worth of DKK 7.87 billion. The enterprise value is 7.58 billion.

Market Cap	7.87B
Enterprise Value	7.58B

Important Dates

The last earnings date was Thursday, November 7, 2024.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	Oct 11, 2024

Share Statistics

ChemoMetec has 17.40 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	17.40M
Shares Change (YoY)	n/a
Shares Change (QoQ)	-0.22%
Owned by Insiders (%)	0.34%
Owned by Institutions (%)	48.77%
Float	17.34M

Valuation Ratios

The trailing PE ratio is 57.75 and the forward PE ratio is 43.28. ChemoMetec's PEG ratio is 8.83.

PE Ratio	57.75
Forward PE	43.28
PS Ratio	19.29
PB Ratio	13.92
P/TBV Ratio	n/a
P/FCF Ratio	72.83
P/OCF Ratio	n/a
PEG Ratio	8.83

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 42.38, with an EV/FCF ratio of 70.13.

EV / Earnings	55.60
EV / Sales	18.58
EV / EBITDA	42.38
EV / EBIT	44.85
EV / FCF	70.13

Financial Position

The company has a current ratio of 4.97, with a Debt / Equity ratio of 0.01.

Current Ratio	4.97
Quick Ratio	3.71
Debt / Equity	0.01
Debt / EBITDA	0.02
Debt / FCF	0.04
Interest Coverage	923.31

Financial Efficiency

Return on equity (ROE) is 24.82% and return on invested capital (ROIC) is 19.03%.

Return on Equity (ROE)	24.82%
Return on Assets (ROA)	15.82%
Return on Capital (ROIC)	19.03%
Revenue Per Employee	2.34M
Profits Per Employee	783,241
Employee Count	174
Asset Turnover	0.61
Inventory Turnover	0.35

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +18.20% in the last 52 weeks. The beta is 1.31, so ChemoMetec's price volatility has been higher than the market average.

Beta (5Y)	1.31
52-Week Price Change	+18.20%
50-Day Moving Average	414.92
200-Day Moving Average	387.14
Relative Strength Index (RSI)	56.56
Average Volume (20 Days)	56,015

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ChemoMetec had revenue of DKK 407.87 million and earned 136.28 million in profits. Earnings per share was 7.83.

Revenue	407.87M
Gross Profit	367.60M
Operating Income	168.97M
Pretax Income	176.59M
Net Income	136.28M
EBITDA	178.78M
EBIT	168.97M
Earnings Per Share (EPS)	7.83

Full Income Statement

Balance Sheet

The company has 296.15 million in cash and 4.16 million in debt, giving a net cash position of 291.99 million or 16.78 per share.

Cash & Cash Equivalents	296.15M
Total Debt	4.16M
Net Cash	291.99M
Net Cash Per Share	16.78
Equity (Book Value)	565.32M
Book Value Per Share	32.48
Working Capital	391.27M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 129.00 million and capital expenditures -20.95 million, giving a free cash flow of 108.06 million.

Operating Cash Flow	129.00M
Capital Expenditures	-20.95M
Free Cash Flow	108.06M
FCF Per Share	6.21

Full Cash Flow Statement

Margins

Gross margin is 90.13%, with operating and profit margins of 41.43% and 33.41%.

Gross Margin	90.13%
Operating Margin	41.43%
Pretax Margin	43.29%
Profit Margin	33.41%
EBITDA Margin	43.83%
EBIT Margin	41.43%
FCF Margin	26.49%

Dividends & Yields

This stock pays an annual dividend of 4.00, which amounts to a dividend yield of 0.89%.

Dividend Per Share	4.00
Dividend Yield	0.89%
Dividend Growth (YoY)	-33.33%
Years of Dividend Growth	1
Payout Ratio	76.62%
Buyback Yield	n/a
Shareholder Yield	0.89%
Earnings Yield	1.73%
FCF Yield	1.37%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ChemoMetec has an Altman Z-Score of 38.72.

Altman Z-Score	38.72
Piotroski F-Score	n/a